longevity science
Longevity Science at Cedars‑Sinai: How Panel Findings Tilt Primary Care Balances
60% of patients ask for off-label senolytics during a primary care visit, but only 2% of those requests have solid clinical backing. The Cedars-Sinai panel shows that these numbers push doctors to weigh ethical, financial, and scientific factors before a prescription ever reaches the pharmacy. Medical Disclaimer: This article is